We will fight for you and have your back no matter what. Join the tens of thousands of people we’ve helped.

36 +
Years
$1 B+
DOLLARS
500 +
clients
20
experts

Cases

Search for a case

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Cases

April 19, 2022

Checkmate Pharmaceuticals, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Checkmate Pharmaceuticals, Inc. (“Checkmate” or the “Company”) (NASDAQ: CMPI), in connection with the proposed acquisition of the Company by Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), via a tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $10.50 in cash for each share of Checkmate common stock owned.

Join Case →

April 19, 2022

American Campus Communities, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of American Campus Communities, Inc. (“ACC” or the “Company”) (NYSE: ACC), in connection with the proposed acquisition of the Company by Blackstone Inc. (NYSE: BX). Under the terms of the merger agreement, the Company’s shareholders will receive $65.47 in cash for each share of ACC common stock owned.

Join Case →

April 18, 2022

Natus Medical Incorporated Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Natus Medical Incorporated (“Natus” or the “Company”) (NASDAQ: NTUS), in connection with the proposed acquisition of the Company by an affiliate of ArchiMed. Under the terms of the merger agreement, the Company’s shareholders will receive $33.50 in cash for each share of Natus common stock owned.

Join Case →

April 18, 2022

Flexible Solutions International Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Flexible Solutions International Inc. (“Flexible Solutions” or the “Company”) (NYSE: FSI) in connection with the proposed merger of the Company with Lygos, Inc. (“Lygos”). Under the terms of the merger agreement, Lygos issued $160 million worth of convertible notes with a 5.5% fixed annual interest rate and a five-year maturity. The conversion price of the convertible note will be set 12 months to the date of the note, and the pricing terms will be set upon the trading price of the future equity but will be set within a market capitalization range of no less than $250 million or no greater than $350 million.

Join Case →

April 14, 2022

Vidler Water Resources, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vidler Water Resources, Inc. (“Vidler” or the “Company”) (NASDAQ: VWTR), in connection with the proposed acquisition of the Company by D.R. Horton, Inc. (NYSE: DHI), via a tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $15.75 in cash for each share of Vidler common stock owned.

Join Case →

April 13, 2022

Antares Pharma, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Antares Pharma, Inc. (“Antares” or the “Company”) (NASDAQ: ATRS), in connection with the proposed acquisition of the Company by Halozyme Therapeutics, Inc. (NASDAQ: HALO) via a tender offer. Under the terms of the merger agreement, the Company’s shareholders will receive $5.60 in cash for each share of Antares common stock owned.

Join Case →

April 13, 2022

Sierra Oncology, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sierra Oncology, Inc. (“Sierra” or the “Company”) (NASDAQ: SRRA), in connection with the proposed acquisition of the Company by GlaxoSmithKline plc (NYSE: GSK). Under the terms of the merger agreement, the Company’s shareholders will receive $55.00 in cash for each share of Sierra common stock owned.

Join Case →

April 11, 2022

SailPoint Technologies Holdings, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of SailPoint Technologies Holdings, Inc. (“SailPoint” or the “Company”) (NYSE: SAIL), in connection with the proposed acquisition of the Company by Thoma Bravo. Under the terms of the merger agreement, the Company’s shareholders will receive $65.25 in cash for each share of SailPoint common stock owned.

Join Case →

April 11, 2022

Datto Holding Corp. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Datto Holding Corp. (“Datto” or the “Company”) (NYSE: MSP) in connection with the proposed acquisition of the Company by Kaseya. Under the terms of the merger agreement, the Company’s shareholders will receive $35.50 in cash for each share of Datto common stock owned.

Join Case →

Where to find us?

new york

305 Broadway, 7th FI
New York, NY 10007
(212) 682-3025

california

8383 Wilshire Blvd., Suite 935
Beverly Hills, CA 90211
(310) 208-2800

georgia

476 Hardendorf Ave. NE
Atlanta, GA 30307
(404) 692-7910

NEW JERSEY

4 Brighton Rd, Suite. 204
Clifton, NJ 07012

Copyright 2022 Weiss Law. All rights reserved

Attorney AdvertisingLegal

Design by Cramdyn